BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.07 by 71.43 percent. This is a 220 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $2.577 billion which beat the analyst consensus estimate of $2.313 billion by 11.41 percent. This is a 27.07 percent increase over sales of $2.028 billion the same period last year.
BrightSpring Health Q1 2024 Adj EPS $0.12 Beats $0.07 Estimate, Sales $2.577B Beat $2.313B Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.